Komori
Terumo (4543) · InitiativeAdvanced

Establishment of the Corporate Governance Committee, Nomination Committee, Internal Control Committee and Risk Management Committee

First written in FY2016. 12 of 17 entries say "Restated". Latest entry: FY2026.

17entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019-Q3RestatedFY2020-Q2 – FY2020-Q3AdvancedFY2022 – FY20242016: 320162017: 320172018: 220182019: 320192020: 120202021: 020212022: 120222023: 020232024: 120242025: 120252026: 22026
Same theme, other companies
Oversight and Risk Management Using Outside DirectorsA theme 88 companies write about · 0 as a headwind · 88 as a tailwind

43 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 88 companies compared. The sentences above are computed from all 88.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「During the fiscal year, with a view to the company's medium- to long-term growth strategy, the committee conducted multifaceted deliberations on the role of the Board of Directors, topics for discussion, the Board's future composition and the appropriate structure of the governance system, among other matters, and reported and provided advice to the Board of Directors.」

    The company not only reconfirmed the establishment of each committee, but also continued deliberations and reporting on the composition of the Board of Directors, the chair, changes to the organizational design, the next medium- to long-term strategy and the business portfolio.
  2. 2026-06-02RestatedGeneral Meetings of Shareholders

    「If elected, he is expected to participate from an independent standpoint as a member of the Nomination Committee, Compensation Committee and Corporate Governance Committee, contributing to deliberations on the selection of candidates for the Company's officers, the determination of officer compensation and other matters related to corporate governance.」

    The Company continued to disclose its deliberative framework involving the Nomination, Compensation and Corporate Governance committees.
  3. FY2025RestatedAnnual report

    「During the fiscal year, the committee continued to deliberate mainly on matters concerning the appointment of directors and executive officers, among other personnel matters, and reported and provided advice to the Board of Directors.」

    The respective Nomination, Compensation and Corporate Governance Committees continue to deliberate and report to and advise the Board of Directors.
  4. FY2024AdvancedAnnual report

    「During the fiscal year, the committee primarily conducted focused deliberations and reached resolutions on the succession of the president and chairperson, one of the Board of Directors' most important responsibilities, and continued deliberations on the appointment of directors and executive officers, among other matters, before reporting and providing advice to the Board of Directors.」

    The Nomination Committee focused its deliberations on the succession of the president and chairperson, reached resolutions, and reported and provided advice to the Board of Directors. The company specifically disclosed the committee structure's operating track record.
  5. FY2022AdvancedAnnual report

    「In addition, to enhance management transparency and objectivity, the company has established the Nomination Committee, Compensation Committee, Corporate Governance Committee, Internal Control Committee and Risk Management Committee as voluntary bodies.」

    The company explicitly presents a five-committee structure and includes important environmental, social and sustainability matters among the matters deliberated by the Corporate Governance Committee.
  6. FY2020-Q3RestatedAnnual report

    「In addition, we have established the Nomination Committee, Compensation Committee and Corporate Governance Committee as voluntary bodies to enhance management transparency and objectivity. From a corporate governance perspective, the Nomination Committee deliberates on the succession of the president and chairperson, one of the Board of Directors' most important responsibilities, as well as matters concerning the appointment and dismissal of directors and executive officers. From the perspective of maintaining and enhancing sound management and corporate governance, the Compensation Committee deliberates and provides advice on matters concerning the compensation of directors and executive officers. The Corporate Governance Committee deliberates and provides advice on important matters concerning the establishment, development and operation of the corporate governance system. Independent outside directors constitute a majority of the members of all 3 committees and also serve as their chairs.」

    The company continues to describe the 3 committees covering nomination, compensation and corporate governance, together with their structure, in which independent outside directors constitute a majority and serve as committee chairs.
  7. FY2020-Q2RestatedAnnual report

    「In addition, we have established the Nomination Committee, Compensation Committee and Corporate Governance Committee as voluntary bodies to enhance management transparency and objectivity. From a corporate governance perspective, the Nomination Committee deliberates on the succession of the president and chairperson, one of the Board of Directors' most important responsibilities, as well as matters concerning the appointment and dismissal of directors and executive officers. From the perspective of maintaining and enhancing sound management and corporate governance, the Compensation Committee deliberates and provides advice on matters concerning the compensation of directors and executive officers. The Corporate Governance Committee deliberates and provides advice on important matters concerning the establishment, development and operation of the corporate governance system. Independent outside directors constitute a majority of the members of all 3 committees and also serve as their chairs.」

    The company continues to describe the matters deliberated by the Nomination Committee, Compensation Committee and Corporate Governance Committee, as well as their structure, in which independent outside directors constitute a majority and serve as committee chairs.
  8. FY2019AdvancedAnnual report

    「In addition, to enhance management transparency and objectivity, the company has established the Nomination Committee, Compensation Committee, Corporate Governance Committee, Internal Control Committee and Risk Management Committee as voluntary bodies.」

    In addition to the committees previously described, the company explicitly presents a five-committee structure that includes the Compensation Committee, established on 1 April 2019.
  9. FY2019-Q3RestatedAnnual report

    「In addition, to enhance management transparency and objectivity, the company has established the Corporate Governance Committee and Nomination Committee as voluntary bodies. The Corporate Governance Committee deliberates and provides advice on strengthening the corporate governance structure and the compensation structure for directors and executive officers. Independent outside directors account for at least half of its members and one of them serves as chair. From a corporate governance perspective, the Nomination Committee deliberates on matters concerning the succession of the president and chairperson, one of the Board of Directors' most important responsibilities, and the appointment and dismissal of directors and executive officers. Independent outside directors account for a majority of its members and one of them serves as chair. The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a framework comprising the Corporate Governance Committee, Nomination Committee, Risk Management Committee and Internal Control Committee.
  10. FY2019-Q2RestatedAnnual report

    「In addition, to enhance management transparency and objectivity, the company has established the Corporate Governance Committee and Nomination Committee as voluntary bodies. The Corporate Governance Committee deliberates and provides advice on strengthening the corporate governance structure and the compensation structure for directors and executive officers. Independent outside directors account for at least half of its members and one of them serves as chair. From a corporate governance perspective, the Nomination Committee deliberates on matters concerning the succession of the president and chairperson, one of the Board of Directors' most important responsibilities, and the appointment and dismissal of directors and executive officers. Independent outside directors account for a majority of its members and one of them serves as chair. The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a framework comprising the Corporate Governance Committee, Nomination Committee, Risk Management Committee and Internal Control Committee.
  11. FY2018-Q3RestatedAnnual report

    「In addition, to enhance management transparency and objectivity, the company has established the Corporate Governance Committee and Nomination Committee as voluntary bodies. It has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a framework comprising the Corporate Governance Committee, Nomination Committee, Risk Management Committee and Internal Control Committee.
  12. FY2018-Q2RestatedAnnual report

    「The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a risk management, compliance and information disclosure framework that includes the Risk Management Committee and Internal Control Committee.
  13. FY2018-Q1RestatedAnnual report

    「The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a governance framework comprising the Risk Management Committee, Internal Control Committee, Corporate Governance Committee and Nomination Committee.
  14. FY2017-Q3RestatedAnnual report

    「The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a framework comprising the Risk Management Committee, Internal Control Committee, Corporate Governance Committee and Nomination Committee.
  15. FY2017-Q2RestatedAnnual report

    「The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a risk management, compliance and information disclosure framework that includes the Risk Management Committee and Internal Control Committee.
  16. FY2017-Q1RestatedAnnual report

    「The company has also established the Risk Management Committee and Internal Control Committee to develop risk management and compliance systems for management and ensure the timely and appropriate disclosure of corporate information.」

    The company continues to describe a framework comprising the Risk Management Committee, Internal Control Committee, Corporate Governance Committee and Nomination Committee.
  17. FY2016First statedAnnual report

    「To enhance management transparency and objectivity, the company has established the Corporate Governance Committee, Nomination Committee, Internal Control Committee and Risk Management Committee as voluntary bodies.」

    Independent outside directors account for at least half of the Governance Committee and a majority of the Nomination Committee.
Moved together

"Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets" moved the same way as this thread, in the same document, in 4 of its 17 moves.

444444★123456
  1. ★This thread
  2. 1Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets4×
  3. 2Expanding market share in global markets and enhancing brand value4×
  4. 3Global sales expansion of cardiovascular products such as Ultimaster4×
  5. 4Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network4×
  6. 5Expansion of R&D and Product Pipeline4×
  7. 6Integration and Strengthening of the Global Production System, Including the Vietnam Factory4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet. It last moved in the General Meetings of Shareholders of 2026-06-02: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Establishment of the Corporate Governance Committee, Nomination Committee, Internal Control Committee and Risk Management Committee | TERUMO CORPORATION (4543) | Komori